Position in NVS
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$746,457
-$19,125 QoQ
Shares Held
4,763
-5.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#725
of 1,603 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Drucker Wealth 3.0, LLC holds $16,211,244 across 10 Drug Manufacturers - General names. NVS ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
23,313 | $5,920,801 | |
| 2 | MRK |
Merck & Co., Inc.
|
21,201 | $2,724,328 | |
| 3 | LLY |
ELI LILLY & Co
|
1,413 | $1,694,794 | |
| 4 | AMGN |
Amgen Inc
|
4,129 | $1,495,192 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
23,639 | $1,362,078 | |
| 6 | ABBV |
AbbVie Inc.
|
2,989 | $752,151 | |
| 7 | NVS |
Novartis AG
This page
|
4,763 | $746,457 | |
| 8 | GSK |
GSK plc
|
12,059 | $632,131 |
All Filings in NVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $746,457 | 4,763 | Shares | Other | 2026-07-13 | |
| 2026-03-31 | $765,582 | 5,012 | Shares | Other | 2026-04-23 | |
| 2025-12-31 | $686,178 | 4,977 | Shares | Other | 2026-02-03 | |
| 2025-09-30 | $641,968 | 5,006 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $677,534 | 5,599 | Shares | Other | 2025-07-24 | |
| 2025-03-31 | $775,231 | 6,954 | Shares | Other | 2025-05-09 | |
| 2024-12-31 | $819,836 | 8,425 | Shares | Other | 2025-02-20 | |
| 2024-09-30 | $1,035,525 | 9,003 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $937,912 | 8,810 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||